About half of smokers seeking help in quitting are depressed or have suffered from depression and related disorders in the past, Anthenelli's team points out in the Annals of Internal Medicine.
"Our prior experience using the medication in smokers with and without mental health disorders, and the results of more than 15 placebo-controlled randomized clinical trials found no such association," he told Reuters Health. Robert Anthenelli of the Veterans Affairs San Diego Healthcare System in California. But the new trial results showing no greater depression risk while quitting smoking with Chantix, even in depression-prone patients, are not surprising according to lead study author Dr. Two years later, the FDA added a "black box warning" about these possible side effects to packages of Chantix and to another drug prescribed for smoking cessation, Zyban. The agency and Chantix manufacturer Pfizer said at the time it was unclear whether the symptoms were caused by the drug or by nicotine withdrawal.
Food and Drug Administration (FDA) announced reports of serious side effects including suicidal thoughts and erratic behavior in some people taking Chantix to stop smoking. as Chantix - were no more prone to depression or thoughts of suicide than those on a placebo, according to a new study. By Kathryn Doyle NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S.